Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left ventricular hypertrophy.

J V Jones1, M A James, T J MacConnell

  • 1Cardiology Department, Royal Infirmary, Bristol, UK.

Journal of Human Hypertension
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experiences of Māori veterinarians and veterinary nurses in the veterinary sector in Aotearoa New Zealand.

New Zealand veterinary journal·2026
Same author

Client experiences with veterinary professionals: a narrative inquiry study.

New Zealand veterinary journal·2024
Same author

Assessing discards in an illegal small-scale fishery using fisher-led reporting.

Reviews in fish biology and fisheries·2022
Same author

Probable Phaeoacremonium parasiticum as a cause of cavitary native lung nodules after single lung transplantation.

Transplant infectious disease : an official journal of the Transplantation Society·2013
Same author

RCPE UK Consensus Conference on 'Approaching the comprehensive management of atrial fibrillation: evolution or revolution?'.

The journal of the Royal College of Physicians of Edinburgh·2012
Same author

RCPE UK Consensus Conference on 'approaching the comprehensive management of atrial fibrillation: evolution or revolution?'.

The journal of the Royal College of Physicians of Edinburgh·2012
Same journal

Previous COVID-19 infection: An overlooked cardiovascular risk factor.

Journal of human hypertension·2026
Same journal

Patient out-of-pocket costs for antihypertensive single pill combination products with cost caps.

Journal of human hypertension·2026
Same journal

Mindfulness based interventions for blood pressure reduction: systematic and umbrella review of existing meta-analyses.

Journal of human hypertension·2026
Same journal

Invasive observation of reactive systolic blood pressure responses to upper-arm cuff inflation.

Journal of human hypertension·2026
Same journal

Association between post-thrombectomy blood pressure trajectories and clinical outcomes in hypertensive patients with acute ischemic stroke: a retrospective cohort study.

Journal of human hypertension·2026
Same journal

Systemic inflammation indices generated from first-trimester blood tests can be potential biomarkers for predicting preeclampsia.

Journal of human hypertension·2026
See all related articles

Pathological left ventricular hypertrophy (LVH) is a risk for cardiovascular events and may progress to fibrosis. Reversal of LVH depends on the stage, with potential interactions with potassium levels impacting treatment.

Area of Science:

  • Cardiology
  • Pathology

Background:

  • Left ventricular hypertrophy (LVH) can be physiological or pathological.
  • Pathological LVH is a known risk factor for cardiovascular events.
  • LVH progression involves hypertrophy, cell death, and myocardial fibrosis.

Purpose of the Study:

  • To investigate the progressive nature of LVH.
  • To explore the potential for LVH reversal based on its stage.
  • To examine the implications of LVH and serum potassium interaction on hypertension treatment.

Main Methods:

  • Review of existing literature on LVH progression and cardiovascular risk.
  • Analysis of the relationship between LVH stages and potential for reversal.
  • Exploration of the interplay between LVH, potassium levels, and antihypertensive therapies.

Related Experiment Videos

Main Results:

  • Pathological LVH, unlike physiological, is linked to cardiovascular events.
  • LVH progression is characterized by a sequence from hypertrophy to fibrosis.
  • The stage of LVH influences the feasibility of its reversal.
  • Serum potassium levels may interact with LVH, affecting therapeutic strategies.

Conclusions:

  • The stage of pathological LVH is critical for determining reversibility.
  • Therapeutic strategies for hypertension, especially involving thiazide diuretics, must consider LVH and potassium levels.